Abstract
During the last ten years the development of radiopharmaceuticals for SPECT was a continuous struggle between radioiodinated compounds and 99mTc labeled radiopharmaceuticals. If 99mTc labeled compounds won as far as pure “routine radiopharmaceuticals” for blood flow, kidneys and heart were concerned, the development of 123I labeled receptor and metabolic tracers gained more interest. The major part of the radioiodinated pharmaceuticals belong to the iodoarylcompounds.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
L. Carlsen, K. Andresen, I-131-Labelled N-Isopropyl-p-Iodoamphetamine, Eur. J. Nucl. Med., 7: 280–281 (1982).
L. Hawkins, A. Elliott, R. Shields et al, A Rapid Quantitative Method for the Preparation of 1–123-lodohippuric Acid, Eur. J. Nucl. Med., 7: 58–61 (1982).
P. Wanek, Notes on the Radioiodination of Hippuric Acid, Radiochem. Radioanal. Lett.; 46: 401–404 (1981).
G.H. Hinkle, G.P. Basmadjan, A.S. Kirschener et al, Kit Preparation of Radioiodinated lodohippuran, J. Pharm. Sciences, 70: 312–316 (1981).
S. Mills, Rapid Synthesis of I-123-Labelled Iodinated Contrast Media by Kittype Labeling Procedure, Int. J. Appl. Radiat. Isot., 33: 467–468 (1982).
P. Angelberger, M. Wagner-Loffler, E. Hruby et al, Radiochemical and Analytical Aspects in Optimized Preparation of I-123-N-Isopropyl-p-Iodoamphetamine, J. Lab. Comp. Radiopharm., 21: 1110–1112 (1984).
T. Horne, L. Hawkins, M. CarolI et al, m-I-123-Benzylguanidine, Synthesis and Imaging the Adrenal and Pheochromocytoma. Presented at the European Nuclear Medicine Congress, Helsinki (1984).
D. Fortman, P. Robbins, V. Sodd, A Study on the Labeling of o-lodohippuric Acid with 1–123, Int. J. Appl. Radiat. Isot., 29: 449–451 (1978).
D. Kuhl, J. Barrio, S. Huang et al, Quantifying Local Cerebral Blood Flow by NIsopropyl-p-I-123-Amphetamine Tomography, J. Nucl. Med., 23: 196–203 (1982).
M. Eisenhut, B. Kimmig, B. Bubeck et al, Labelling of I-131-Metaiodobenzylguanidine with High Specific Activity for Radiotherapeutic Purposes, J. Lab. Comp. Radiopharm., 21: 1130–1132 (1984).
D. Wieland, J. Wu, L. Brown et al, Radiolabelled Adrenergic Neuron Blocking Agents: Adrenomedullary Imaging with 1–141-lodobenzylguanidine, J. Nucl. Med., 21: 349–353 (1980).
S. M. Moerlein, D-R. Hwang, M.J. Welch,No-Carrier-Added Radiobromination via Cuprous Chloride-Assisted Nucleophilic Aromatic Bromodeiodination, Int. J. Appl. Radiat. Isot., 39: 369–372 (1988).
J. Mertens, W. Vanryckeghem, L. Carlsen, 1986, Cu(I) Supported Isotopic Exchange of Arylbound Iodide, New Future for Fast High Yield Labeling, in: Progress in Radiopharmacy, 101–109, P.H. Cox et al, ed., M. Nijhoff, pubi., Dordrecht, The Netherlands.
J. Mertens, M. Gysemans, C. Piron et al, High Yield Preparation of Pure 2Radioiodo-Ketanserin of High Specific Activity, A Serotonin S2 Receptor Tracer for SPECT, J. Lab. Comp. Radiopharm., 28: 732–738 (1990).
J. Mertens, W. Vanryckeghem, M. Gysemans et al, New Fast Preparation of I-123 Labeled Radiopharmaceuticals, Eur. J. Nucl. Med., 13: 380–381 (1987)
J. Mertens, W. Vanryckeghem, 1985, Fast Quantitative Labelling of N-Isopropylp-Iodoamphetamine with I-123 in Presence of Cu(I) and Ascorbic Acid, Allowing Kit-Form Preparation, in: Radiopharmaceuticals and Labelled Compounds, 303–310, IAEA, ed., Vienna.
W. Vanryckeghem, J. Mertens, Fast Quality Control of I-123-Labelled Radiopharmaceuticals by means of Small Size Columns, Proceedings 2nd European Symposium on Radiopharmacy and Radiopharmaceuticals, Cambridge (1985).
W. Vanryckeghem, J. Mertens, Determination of the Quality of I-123 and 1–131 Solution by means of Ion-Pair Radiochromatography, J. Lab. Comp. Radiopharm., 27: 137–139 (1989).
J. Mertens, M. Gysemans, W. Vanryckeghem et al, New high Yield Cu(I) Assisted Nucleophilic Radiobromination, J. Lab. Comp. Radiopharm., 23: 12731275 (1986).
J. Mertens, A. Callaerts, W. Vanryckeghem, New Realistic Approach of the Kinetics in Fast Labeling Procedures, J. Lab. Comp. Radiopharm., 24: 607–612 (1986).
V. Stanko, N. Iroshinikova, A. Volkov et al, Int. J. Appl. Radiat. Isot., 35: 11291132 (1984).
M. Tarie, R. Padovan, S. Spaventi, Radioiodination of Iodinated Estradiol-17Diphosphates, J. Lab. Comp. Radiopharm., 20: 7–21 (1978).
T. Cohen, J. Wood, A. G. Dietz, Organocopper Intermediates in the Exchange Reaction of Aryl Halides with Salts of Copper(I), Tetrahedron Lett., 40: 35553558 (1974).
J. Lindley, Copper Assisted Nucleophilic Substitution of Aryl Halogen, Tetrahedron, 40: 1433–1456 (1984).
B. Liedholm, Copper(I) Catalyzed Replacement of Iodine by Chloride Ion in Halonitrobenzenes, Acta Chem. Scand., 25: 113–117 (1971).
B. Liedholm, Copper(I) Catalyzed Replacement of Iodine by Chloride Ion in Halonitrobenzenes. Part II, Acta Chem. Scand., 30: 141–149 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mertens, J., Gysemans, M. (1991). CU1+Assisted Nucleophilic Exchange Radiohalogenation: Application and Mechanistic Approach. In: Emran, A.M. (eds) New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0626-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0626-7_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0628-1
Online ISBN: 978-1-4899-0626-7
eBook Packages: Springer Book Archive